← FDA DRUG APPROVALS

FDA ANDA · ANDA073591

LACTULOSE

Sponsor: HIKMA

APPLICATION
ANDA073591
TYPE
ANDA
ORIGINAL APPROVAL
1992-05-29
LATEST ACTION
2008-02-06
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

LACTULOSEDiscontinued
LACTULOSE 10GM/15ML · SOLUTION · ORAL

Approval history

2008-02-06Labeling · Supplement 19AP
2002-10-23Manufacturing (CMC) · Supplement 15AP
2000-11-30Manufacturing (CMC) · Supplement 14AP
2000-03-27Manufacturing (CMC) · Supplement 12AP
1998-09-02Manufacturing (CMC) · Supplement 13AP
1996-12-11Manufacturing (CMC) · Supplement 10AP
1996-12-11Manufacturing (CMC) · Supplement 9AP
1996-09-20Manufacturing (CMC) · Supplement 8AP
1996-09-20Manufacturing (CMC) · Supplement 6AP
1996-09-20Labeling · Supplement 7AP
1996-08-28Manufacturing (CMC) · Supplement 5AP
1995-08-18Manufacturing (CMC) · Supplement 4AP
1995-08-18Labeling · Supplement 2AP
1995-08-18Manufacturing (CMC) · Supplement 1AP
1995-02-08Labeling · Supplement 3AP
1992-05-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →